Morning Briefing
Summaries of health policy coverage from major news organizations
Financial Times Contrasts 'Bottom Up' And 'Top Down' Approaches To Developing Country Drugs
The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
